Axsome Therapeutics Inc (AXSM)
78.87
-0.35
(-0.44%)
USD |
NASDAQ |
Mar 28, 13:07
Axsome Therapeutics Cash from Operations (TTM): -145.08M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -145.08M |
September 30, 2023 | -142.28M |
June 30, 2023 | -111.49M |
March 31, 2023 | -89.68M |
December 31, 2022 | -116.51M |
September 30, 2022 | -117.79M |
June 30, 2022 | -121.81M |
March 31, 2022 | -113.66M |
December 31, 2021 | -108.23M |
September 30, 2021 | -99.94M |
June 30, 2021 | -88.90M |
March 31, 2021 | -82.40M |
December 31, 2020 | -78.46M |
September 30, 2020 | -75.47M |
June 30, 2020 | -70.36M |
March 31, 2020 | -60.15M |
December 31, 2019 | -46.38M |
Date | Value |
---|---|
September 30, 2019 | -38.60M |
June 30, 2019 | -33.89M |
March 31, 2019 | -32.87M |
December 31, 2018 | -30.05M |
September 30, 2018 | -26.55M |
June 30, 2018 | -27.09M |
March 31, 2018 | -26.52M |
December 31, 2017 | -26.47M |
September 30, 2017 | -27.40M |
June 30, 2017 | -25.75M |
March 31, 2017 | -23.97M |
December 31, 2016 | -21.28M |
September 30, 2016 | -16.32M |
June 30, 2016 | -13.44M |
March 31, 2016 | -10.23M |
December 31, 2015 | -7.439M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-145.08M
Minimum
Dec 2023
-32.87M
Maximum
Mar 2019
-88.70M
Average
-89.29M
Median
Cash from Operations (TTM) Benchmarks
Vertex Pharmaceuticals Inc | 3.537B |
Amgen Inc | 8.471B |
ResMed Inc | 1.079B |
Alnylam Pharmaceuticals Inc | 104.16M |
Ionis Pharmaceuticals Inc | -307.51M |